Armis Advisers’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Armis Advisers's BCAT Position: Q2 2026 in Review
Armis Advisers increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 1.5% in Q2 2026, buying an estimated $7.72K and bringing the position to 33,077 shares worth $529K. The position accounts for 0.05% of the portfolio, ranked #264.
Armis Advisers first reported a position in BCAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $655K in Q2 2025. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Armis Advisers held 33,077 shares of BlackRock Capital Allocation Term Trust worth $529K as of Q2 2026.
- Armis Advisers bought 503 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $7.72K.
- BlackRock Capital Allocation Term Trust made up 0.05% of Armis Advisers's portfolio in Q2 2026, its #264 holding.
- Armis Advisers first reported a position in BlackRock Capital Allocation Term Trust in Q1 2025 and has held it in 6 quarters since.
- Armis Advisers's BlackRock Capital Allocation Term Trust position peaked at $655K in Q2 2025.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.